Association between glycemic control and dietary patterns in patients with type 2 diabetes in a Mexican institute.

Dietary pattern Glycemic control Healthy pattern Mexico Type 2 diabetes Western-style pattern

Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
10 2020
Historique:
received: 28 02 2020
revised: 02 04 2020
accepted: 27 05 2020
pubmed: 1 8 2020
medline: 24 6 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate the association between glycemic control (hemoglobin (Hb) A1c <7%) and the dietary patterns identified in Mexican patients with type 2 diabetes mellitus (T2DM). This was a secondary analysis conducted with 4838 patients with T2DM in Mexico. Biochemical blood profiles, socioeconomic level, anthropometric measurements, and dietary data were obtained. Dietary data from a food frequency questionnaire were used to derive dietary patterns. Factor analysis was conducted to ascertain dietary patterns, and multivariate analysis was fitted to assess the relationship between glycemic control and consumption of dietary patterns. Three dietary patterns were identified. After control for potential cofounders (age, sex, duration of T2DM, body mass index, pharmacologic treatment, intensity of physical activity, socioeconomic level, and kcal/kg ideal weight), we found that consuming a Western-style diet (odds ratio [OR], 1.533, 95% confidence interval [CI], 1.253-1.875; P < 0.000), and the sweets and dairy diet (fats and sugars; OR, 1.444; 95% CI, 1.133-1.841; P = 0.003) patterns were associated with HbA1c ≥7%, whereas consuming a healthy dietary patter (OR, 0.800; 95% CI, 0.642-0.998; P = 0.048) was associated with HbA1c <7%. Consuming a healthy diet was associated with glycemic control; whereas the Western-style or sweets and dairy patterns promoted a lack of metabolic control. These results support the promotion of a healthy pattern in the Mexican population with T2DM.

Identifiants

pubmed: 32736300
pii: S0899-9007(20)30184-2
doi: 10.1016/j.nut.2020.110901
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110901

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Mónica Leonor Ruiz Martínez (MLR)

Hospital de Gineco-Pediatría 3 A, Centro Médico Nacional "La Raza," Mexico City, Mexico.

Rita Angélica Gómez-Díaz (RA)

Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Adriana Leticia Valdez González (ALV)

Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Rafael Mondragón González (RM)

Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Martha Catalina Sánchez Becerra (MCS)

Unidad de Investigación en Bioquímica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Sandra Lorena García Del Rio (SLGD)

Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Miguel Cruz (M)

Unidad de Investigación en Bioquímica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Niels Hansen Wacher-Rodarte (NH)

Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Electronic address: wacherniels@gmail.com.

Ramon Alberto Rascón Pacheco (RAR)

Coordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Víctor Hugo Borja Aburto (VHB)

Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH